forecast

CRISPR's first clinical use will target severe congenital disease

CRISPR will likely reach human clinical use first for severe congenital diseases, because patients with horrible conditions make the bar for experimental treatment much lower than for enhancement.

forecastpending

Speaker

Eli Dourado

Evidence Quote

“I think it will be used there first”

Source

Eli Dourado - Frontiers for Productivity - [Invest Like the Best, EP. 225]— Invest Like the Best
Created: 11/11/2026, 6:38:30 AM

Your notes

Loading notes...